|
G |
CAT |
catalase |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] promotes the reaction [bisphenol A results in decreased expression of CAT protein]; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT mRNA; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT protein |
CTD |
PMID:29129240 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CBS |
cystathionine beta-synthase |
multiple interactions increases activity |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of CBS protein Folic Acid deficiency results in increased activity of CBS protein |
CTD |
PMID:16792574 |
|
NCBI chr13:206,205,942...206,231,363
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions |
EXP |
[Folic Acid co-treated with Glycine] results in decreased expression of CSF2 mRNA |
CTD |
PMID:14662146 |
|
NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
|
|
G |
CTH |
cystathionine gamma-lyase |
multiple interactions |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of CTH protein |
CTD |
PMID:16792574 |
|
NCBI chr 6:142,454,922...142,486,352
Ensembl chr 6:142,435,690...142,486,367
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,564...69,029,919
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT3A mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,609,139
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
multiple interactions |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of GCLC protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GCLC mRNA |
CTD |
PMID:16792574 |
|
NCBI chr 7:27,209,565...27,253,535
Ensembl chr 7:27,209,564...27,253,535
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of GPX1 mRNA; [bisphenol A co-treated with [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12]] results in increased expression of GPX1 mRNA |
CTD |
PMID:29129240 |
|
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,914,932...31,917,335
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions increases activity increases expression |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSR protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSR mRNA Folic Acid deficiency results in increased activity of GSR protein Folic Acid deficiency results in increased expression of GSR mRNA |
CTD |
PMID:16792574 |
|
NCBI chr15:54,382,564...54,433,989
Ensembl chr15:54,382,567...54,433,989
|
|
G |
GSS |
glutathione synthetase |
multiple interactions |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSS protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSS mRNA |
CTD |
PMID:16792574 |
|
NCBI chr17:38,316,199...38,342,253
Ensembl chr17:38,312,720...38,342,304
|
|
G |
GSTA1 |
glutathione S-transferase alpha 1 |
increases expression multiple interactions |
EXP |
Folic Acid deficiency results in increased expression of GSTA1 mRNA [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSTA1 mRNA |
CTD |
PMID:16792574 |
|
NCBI chr 7:46,538,743...46,550,781
Ensembl chr 7:46,538,032...46,567,728
|
|
G |
GYS1 |
glycogen synthase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Folic Acid co-treated with bisphenol A] results in increased methylation of GYS1 promoter; [Betaine co-treated with Choline co-treated with Folic Acid] results in decreased expression of GYS1 mRNA; [Betaine co-treated with Choline co-treated with Folic Acid] results in increased methylation of GYS1 promoter |
CTD |
PMID:29065941 |
|
NCBI chr 6:54,234,600...54,250,211
Ensembl chr 6:54,233,050...54,250,261
|
|
G |
LDHA |
lactate dehydrogenase A |
multiple interactions |
EXP |
[bisphenol A co-treated with Choline co-treated with Folic Acid co-treated with Betaine] results in decreased methylation of LDHA promoter |
CTD |
PMID:29065941 |
|
NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,812,453...40,826,715
|
|
G |
MTHFR |
methylenetetrahydrofolate reductase |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of MTHFR mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,636...71,881,820
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
[Folic Acid co-treated with Glycine] results in decreased expression of PTGS1 |
CTD |
PMID:14662146 |
|
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[Folic Acid co-treated with Glycine] results in increased expression of PTGS2 |
CTD |
PMID:14662146 |
|
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,013...127,858,884
|
|
G |
SI |
sucrase-isomaltase |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SI mRNA |
CTD |
PMID:28445388 |
|
NCBI chr13:104,296,281...104,379,558
Ensembl chr13:104,296,283...104,379,478
|
|
G |
SLC15A1 |
solute carrier family 15 member 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of SLC15A1 mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased methylation of SLC15A1 promoter]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC15A1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr11:67,652,808...67,690,457
Ensembl chr11:67,652,193...67,710,933
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with bisphenol A] results in increased expression of SLC5A1 mRNA; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC5A1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr14:48,566,400...48,704,145
Ensembl chr14:48,566,343...48,705,841
|
|
G |
SOD1 |
superoxide dismutase 1 |
decreases activity multiple interactions |
EXP |
Folic Acid deficiency results in decreased activity of SOD1 protein [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of SOD1 mRNA; [Ethanol co-treated with Folic Acid deficiency] results in decreased activity of SOD1 protein |
CTD |
PMID:16792574 PMID:29129240 |
|
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,749
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions increases activity |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of SOD2 protein Folic Acid deficiency results in increased activity of SOD2 protein; Folic Acid results in increased activity of SOD2 protein |
CTD |
PMID:16792574 PMID:22889112 |
|
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,651,280...7,691,723
|
|